Article,

Statistical significance testing and clinical trials.

.
Psychotherapy (Chicago, Ill.), 48 (3): 217-22 (September 2011)7061<m:linebreak></m:linebreak>CI: (c) 2011; JID: 2984829R; CIN: Psychotherapy (Chic). 2011 Sep;48(3):229-30; discussion 234-6. PMID: 21875237; CIN: Psychotherapy (Chic). 2011 Sep;48(3):225-8; discussion 234-6. PMID: 21875236; CIN: Psychotherapy (Chic). 2011 Sep;48(3):223-4; discussion 234-6. PMID: 21875235; CIN: Psychotherapy (Chic). 2011 Sep;48(3):231-3; discussion 234-6. PMID: 21875238; ppublish;.
DOI: 10.1037/a0022088

Abstract

The efficacy of treatments is better expressed for clinical purposes in terms of these treatments' outcome distributions and their overlapping rather than in terms of the statistical significance of these distributions' mean differences, because clinical practice is primarily concerned with the outcome of each individual client rather than with the mean of the variety of outcomes in any group of clients. Reports of the obtained outcome distributions for the comparison groups of all competently designed and executed randomized clinical trials should be publicly available no matter what the statistical significance of the mean differences among these groups, because all of these studies' outcome distributions provide clinically useful information about the efficacy of the treatments compared.

Tags

Users

  • @jepcastel

Comments and Reviews